Imricor Medical Systems, Inc. (IMR.AX) research: valuation against peers, fundamentals over time, risk and news coverage
ChartVs peersValuationValue mapQuartersScaleMarginsTrajectoryCash qualityPer shareReinvestmentBalance sheetStreetRiskSeasonalityOur coverage
IMR.AX
Imricor Medical Systems, Inc.AUD
1.94
-3.48% today
Market cap
—
P/E trailing
—
P/E forward
—
EV/EBITDA
—
Op margin
—
Rev growth
—
Div yield
—
Beta
—
Price navigator — IMR.AX
No data in this window.
INDY NEWS coverage of IMR.AX1
Every report in our own archive tagged with this symbol, newest first — fetched from the archive alongside the market data.
- MARKET REPORTNEUTRALImricor logs minimal revenue as U.S. commercial launch begins
Imricor reported negligible first-half revenue but said it had secured additional FDA clearances as it starts selling its MRI-guided cardiac ablation products in the United States.
Every figure on this page is fetched and computed in your browser from free public sources — end-of-day prices and reported financials from Yahoo Finance's open endpoints, and our own archive for the coverage panel. Fundamental history on the free tier runs about four fiscal years and five quarters. Data is best-effort and unaudited; this is market research, not investment advice.